CLINICAL_TRIALS
withdrawal
· 2022-07-26
Clinical Trial Update: Use of Tranexamic Acid in Facial Fillers [Phase 4]
Summary
Phase 4 trial exploring tranexamic acid for injection site bruising in facial fillers was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Injection Site Bruising | Phase 4 | Status: WITHDRAWN